Decreasing Duration of Antibiotic Prescribing for Uncomplicated Skin and Soft Tissue Infections

Pediatrics
Christine L SchulerCraig H Gosdin

Abstract

Short courses of antibiotics are often indicated for uncomplicated skin and soft tissue infections (uSSTIs). Our objective was to decrease duration of antibiotics prescribed in children hospitalized for uSSTIs by using quality improvement (QI) methods. QI methods were used to decrease duration of antibiotics prescribed upon hospital discharge for uSSTIs. We sought to accomplish this goal by increasing outpatient prescriptions for short courses of therapy (≤7 days). Key drivers included awareness of evidence among physicians, changing the culture of prescribing, buy-in from prescribers, and monitoring of prescribing. Physician education, modification of antibiotic order sets for discharge prescriptions, and continual identification and mitigation of therapy plans, were key interventions implemented by using plan-do-study-act cycles. A run chart assessed the impact of the interventions over time. We identified 641 index admissions for uSSTIs over a 23-month period for patients aged >90 days to 18 years. The proportion of children discharged with short courses of antibiotics increased from a baseline median of 23% to 74%, which was sustained for 6 months. Differences in the proportion of children admitted for treatment failure or ...Continue Reading

References

Jan 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuUNKNOWN Infectious Diseases Society of America
Feb 16, 2011·Nature Immunology·Mercy PrabhuDasClaire-Anne Siegrist
Mar 16, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·UNKNOWN Society for Healthcare Epidemiology of AmericaUNKNOWN Pediatric Infectious Diseases Society
Sep 26, 2012·Antimicrobial Agents and Chemotherapy·Fawziah MarraWilliam R Bowie
Oct 3, 2012·Archives of Pediatrics & Adolescent Medicine·Ron KerenUNKNOWN Pediatric Research in Inpatient Settings (PRIS) Network
Jun 21, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensJames C Wade

❮ Previous
Next ❯

Citations

Dec 22, 2017·Journal of the Pediatric Infectious Diseases Society·Matthew P KronmanJason G Newland
Jan 17, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison C TribbleUNKNOWN Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative
Sep 2, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lindsay M Daniels, David J Weber
Jan 23, 2018·Current Opinion in Infectious Diseases·Silvia Corcione, Francesco Giuseppe De Rosa
Nov 23, 2017·Acta Odontologica Scandinavica·Hyesung KimHyungkil Choi
Jul 19, 2021·The Journal of Pediatrics·Holly M FrostTimothy C Jenkins
Sep 24, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Valerie M VaughnEmily S Spivak
Jan 5, 2019·Pediatrics·Laila F IbrahimPenelope A Bryant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.